biotech · Pulmonary Arterial Hypertension · Pulmonary Arterial Hypertension (PAH) · IKT
Inhibikase Therapeutics
Inhibikase Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.
Wilmington, USA HQ
29 Employees
Public company Type
IKT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Wilmington, USA
- Employees
- 29
- Programs
- 4
- Drugs
- 5
- Patents
- 9
Events
Inhibikase Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.
Inhibikase Therapeutics events on NovaPharmaNews — congress presentations and investor conference coverage.